Association of Prescription of Oral Sodium Polystyrene Sulfonate With Sorbitol in an Inpatient Setting With Colonic Necrosis: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Association of Prescription of Oral Sodium Polystyrene Sulfonate With Sorbitol in an Inpatient Setting With Colonic Necrosis: A Retrospective Cohort Study

Published:2012-09 Issue:3 Volume:60 Page:409-416
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Watson Maura A.,Baker Thomas P.,Nguyen Annie,Sebastianelli Mary E.,Stewart Heather L.,Oliver David K.,Abbott Kevin C.,Yuan Christina M.

Publisher

Elsevier BV

Subject

Nephrology

Reference35 articles.

1. Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis;Lillemoe;Surgery,1987

2. Colonic necrosis with Kayexalate-sorbitol enemas after renal transplantation;Wootton;Ann Intern Med,1989

3. Sodium polystyrene-sorbitol enemas;Burnett;Ann Intern Med,1990

4. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an under-recognized condition;Rashid;Am J Surg Pathol,1997

5. Kayexalate (sodium polystyrene sulphonate) in sorbitol associated with intestinal necrosis in uremic patients;Gardiner;Can J Gastroenterol,1997

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correction of Electrolyte Abnormalities in Critically Ill Patients;Intensive Care Research;2024-01-22

2. Therapeutic update on oral potassium exchange resin use in chronic kidney disease patients: a systematic review of randomized controlled clinical trials;Journal of Pharmacy & Pharmaceutical Sciences;2023-12-20

3. Comprehensive analysis of sodium polystyrene sulfonate-induced colitis: A systematic review;World Journal of Meta-Analysis;2023-12-18

4. Potassium homeostasis – Physiology and pharmacology in a clinical context;Pharmacology & Therapeutics;2023-09

5. Hyperkalemia in chronic kidney disease: a focus on potassium lowering pharmacotherapy;Expert Opinion on Pharmacotherapy;2023-08-13